Kalaris Therapeutics Inc logo

KLRS Earnings Date: Nov 11, 2026 (Estimated) — Kalaris Therapeutics Inc

NASDAQ · Healthcare · Biotechnology

Updated

Price $2.08
Market Cap $49.5M
P/E -0.9
52W Range $1.78 – $11.88
Next Earnings · Before open (est.)

When is KLRS's next earnings date?

Kalaris Therapeutics Inc (KLRS) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 9:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.52.

How did KLRS do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Kalaris Therapeutics Inc posted EPS of -$0.48 versus the -$0.49 estimate, a beat of 4.0%. Revenue was $0. The stock's 1-day post-earnings move was +0.8%.

How much does KLRS stock move after earnings?

KLRS beat EPS estimates in 3 of its last 5 reported quarters. Over the last 5 reports the stock moved an average of 3.2% (up or down) in the day after earnings.

About Kalaris Therapeutics Inc

Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases. It develops TH103, a clinical-stage anti-vascular endothelial growth factor (VEGF) drug for the treatment of neovascular age-related macular degeneration (nAMD), as well as for the treatment of other exudative and neovascular retinal diseases.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.49-0.48+4.00%$0✅ Beat+0.76%+0.51%-11.93%
2026-05-12Q1 2026-0.52-0.46+11.54%$0✅ Beat+1.27%+0.21%-12.05%
2026-03-17Q4 2025-0.55-0.44+20.00%$0✅ Beat-3.29%-26.22%-33.37%
2025-11-12Q3 2025-0.63-0.64-1.59%$0❌ Miss-2.17%+27.22%+64.30%
2025-08-13Q2 2025-0.51-0.61-19.61%$0❌ Miss-8.43%+3.21%+71.89%
2022-12-30—-9.42——————
2022-09-29—-11.39——————
2022-06-29—-15.93——————

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .